TOLERIANE DERMALLERGO EYES

  • 20min
  • May. 2022
  • Supported by
  • La Roche-Posay

A recent clinical study has been released, evaluating the ocular and peri-ocular tolerance and the efficacy of TOLERIANE DERMALLERGO EYES.

The open study La Roche-Posay conducted, included male and female subjects of the caucasian type, over the age 18 who show palpebral eczema or sensitive skin, especially around the eyes.

Already 10 min after application, TOLERIANE DERMALLERGO EYES shows an average reduction of 26% on the intensity of the below listed functional signs. After 14 days of application, the average decrease of proportion is 41%. Finally, after 28 days of use there is a general reduction of 63% for the investigated functional signs. 

 

 

After 14 and 28 days TOLERIANE DERMELLERGO EYES significantly lowers the intensity of the following physical signs with a minimum of 55%

After 28 days of use, the skin is more resistant and less reactive to external aggressions, therefore the redness reduced.
BEFORE AFTER YEUX

Illustrative photo, mean case

Next, a self-assessment and clinical evaluation by dermatologists was included in the study. Thanks to its soothing and repairing action:

  • 73% of the subjects improved their irritated aspect of the eye contours
  • 65% of the subjects improved their swelling of the eye contours
  • 60% of the subjects improved their soothing feeling of eye contours

Finally, the tolerance was judged VERY GOOD by the dermatologists and the ophthalmologists and no functional signs were reported for the ophthalmological examination for all the subjects.

How to use it?

Apply to eye contour 1 to 2 times a day, in the morning and/or evening.